OraSure to Participate in Upcoming Investor Conference
OraSure Technologies (NASDAQ: OSUR) will participate in the Stephens Annual Investment Conference on Wednesday, November 19, 2025. The company’s session includes a Q&A at 10:00 a.m. CT.
A live webcast and replay of the Q&A will be available on the company’s investor relations events page at https://orasure.gcs-web.com/events-and-presentations.
OraSure Technologies (NASDAQ: OSUR) parteciperà alla Stephens Annual Investment Conference mercoledì 19 novembre 2025. La sessione dell'azienda prevede un Q&A alle ore 10:00 CT.
Una trasmissione in diretta e la replica del Q&A saranno disponibili sulla pagina degli eventi delle relazioni con gli investitori dell'azienda all'indirizzo https://orasure.gcs-web.com/events-and-presentations.
OraSure Technologies (NASDAQ: OSUR) participará en la Stephens Annual Investment Conference el miércoles 19 de noviembre de 2025. La sesión de la empresa incluye un Q&A a las 10:00 a.m. CT.
Una transmisión en vivo y la repetición del Q&A estarán disponibles en la página de eventos de relaciones con inversores de la empresa en https://orasure.gcs-web.com/events-and-presentations.
OraSure Technologies (NASDAQ: OSUR)은 2025년 11월 19일 수요일에 열리는 Stephens Annual Investment Conference에 참가합니다. 회사 세션에는 오전 10:00 CT의 Q&A가 포함되어 있습니다.
생방송 웹캐스트와 Q&A의 재생은 회사의 IR 이벤트 페이지 https://orasure.gcs-web.com/events-and-presentations에서 이용 가능합니다.
OraSure Technologies (NASDAQ : OSUR) participera à la Stephens Annual Investment Conference le mercredi 19 novembre 2025. La session de la société comprend une session de questions-réponses à 10h00 CT.
Une diffusion en direct et le replay du Q&A seront disponibles sur la page des événements des relations investisseurs de l'entreprise à l'adresse https://orasure.gcs-web.com/events-and-presentations.
OraSure Technologies (NASDAQ: OSUR) wird an der Stephens Annual Investment Conference am Mittwoch, dem 19. November 2025, teilnehmen. Die Sitzung des Unternehmens beinhaltet eine Q&A um 10:00 Uhr CT.
Eine Live-Übertragung und der Replay des Q&A werden auf der Seite der Investor Relations-Veranstaltungen des Unternehmens unter https://orasure.gcs-web.com/events-and-presentations verfügbar sein.
ستشارك OraSure Technologies (NASDAQ: OSUR) في مؤتمر Stephens السنوي للاستثمار يوم الأربعاء 19 نوفمبر 2025. تتضمن جلسة الشركة فقرة أسئلة وأجوبة في الساعة 10:00 صباحاً بتوقيت CT. ستكون هناك بث حي وإعادة عرض للأسئلة والأجوبة متاحان على صفحة فعاليات علاقات المستثمرين الخاصة بالشركة على الرابط https://orasure.gcs-web.com/events-and-presentations.
- None.
- None.
BETHLEHEM, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference:
- Stephens Annual Investment Conference on Wednesday, November 19, with a Q&A session scheduled for 10 a.m. CT
A live webcast and replay of the Q&A session will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations.
About OraSure Technologies, Inc.
OraSure Technologies, Inc. (“OraSure” and “OTI”) transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. OTI improves access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. Together with its wholly-owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., OTI is a leader in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. OTI’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct to consumers. For more information, please visit www.orasure.com
| Investor Contact: | Media Contact: |
| Jason Plagman | Amy Koch |
| VP, Investor Relations | Director, Corporate Communications |
| investorinfo@orasure.com | media@orasure.com |